Nagehan Emiralioglu

About Nagehan Emiralioglu

Nagehan Emiralioglu, With an exceptional h-index of 16 and a recent h-index of 15 (since 2020), a distinguished researcher at Hacettepe Üniversitesi,

His recent articles reflect a diverse array of research interests and contributions to the field:

Successful atorvastatin treatment of pulmonary alveolar proteinosis in a child with GM-CSF receptor deficiency.

Exercise performance in children and adolescents with cystic fibrosis with and without abnormal glucose tolerance: a single center cross-sectional study

Comparison of lung ultrasonography and magnetic resonance imaging versus computed tomography in pulmonary alveolar microlithiasis

Nintedanib Treatment in a Child with Pulmonary Fibrosis

Childhood interstitial lung disease in Turkey: first data from the national registry

A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia

Galectin-3 levels in children with cystic fibrosis.

The airway microbiota in siblings with primary ciliary dyskinesia: Related factors and correlation with clinical characteristics

Nagehan Emiralioglu Information

University

Position

Faculty of Medicine

Citations(all)

1098

Citations(since 2020)

965

Cited By

355

hIndex(all)

16

hIndex(since 2020)

15

i10Index(all)

30

i10Index(since 2020)

27

Email

University Profile Page

Google Scholar

Top articles of Nagehan Emiralioglu

Successful atorvastatin treatment of pulmonary alveolar proteinosis in a child with GM-CSF receptor deficiency.

Pediatric Pulmonology

2024/2/27

Exercise performance in children and adolescents with cystic fibrosis with and without abnormal glucose tolerance: a single center cross-sectional study

Physiotherapy Theory and Practice

2024/2/1

Comparison of lung ultrasonography and magnetic resonance imaging versus computed tomography in pulmonary alveolar microlithiasis

Pediatric pulmonology

2024/1/12

Nagehan Emiralioglu
Nagehan Emiralioglu

H-Index: 11

Mithat Haliloglu
Mithat Haliloglu

H-Index: 14

Nintedanib Treatment in a Child with Pulmonary Fibrosis

Türkiye Çocuk Hastalıkları Dergisi

2024/1/1

Childhood interstitial lung disease in Turkey: first data from the national registry

European Journal of Pediatrics

2024/1

A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia

ERJ open research

2024/1/1

Galectin-3 levels in children with cystic fibrosis.

European Journal of Pediatrics

2024/3/2

Dilber Ademhan Tural
Dilber Ademhan Tural

H-Index: 2

Nagehan Emiralioglu
Nagehan Emiralioglu

H-Index: 11

The airway microbiota in siblings with primary ciliary dyskinesia: Related factors and correlation with clinical characteristics

Pediatric Pulmonology

2024/3

Association between upper and lower respiratory disease among patients with primary ciliary dyskinesia: an international study

ERJ Open Research

2024/3/1

EPS8. 07 Relationship between circulating irisin levels with exercise capacity and muscle function in cystic fibrosis

Journal of Cystic Fibrosis

2023/6/1

Lung function and airway microbiology in primary ciliary dyskinesia (PCD): cross-sectional analysis from the PROVALF-PCD cohort, a BEAT-PCD Collaboration

2023/9/9

Diffuse alveolar haemorrhage in children: an international multicentre study

ERJ open research

2023/3/1

P172 CFTR Modulators in children with cystic fibrosis: real-life evidence in Turkey

Journal of Cystic Fibrosis

2023/6/1

Immunoglobulin A vasculitis in a child: Secondary to COVID‐19 or cystic fibrosis?

Pediatric pulmonology

2023/2

Nagehan Emiralioglu
Nagehan Emiralioglu

H-Index: 11

Seza Ozen
Seza Ozen

H-Index: 55

Diagnosis and Treatment of Drug-Resistant Tuberculosis

Turkiye Klinikleri Pediatric Chest Diseases-Special Topics

2023

The role of flexible bronchoscopy in the diagnostic pathway of children with unexplained peripheral eosinophilia

Pediatrics International

2023/1

Evaluation of respiratory function at 6 years of age in patients with cystic fibrosis with frequent pulmonary exacerbations in the first 2 years of life

2023/9/9

P224 Eligibility of CFTR Modulator [HB1] drugs in patients registered in cystic fibrosis registry of Turkey

Journal of Cystic Fibrosis

2023/6/1

Association between lung ultrasound findings, pulmonary function tests and chest radiography in children with cystic fibrosis

2023/9/9

P314 Cystic fibrosis related to bone disease in children: can it be predicted?

2023/6/1

See List of Professors in Nagehan Emiralioglu University(Hacettepe Üniversitesi)